Search

everythinglearnresearchcommunity

for

Search:↓

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

A male with aromatase deficiency improved bone health with estradiol treatment.

The study found that women with PCOS have more and larger ovarian follicles and differences in ovarian structure, but these features alone can't always diagnose PCOS.

Minoxidil effectively treats female pattern hair loss.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Microneedles with enhancer effectively promote hair growth and increase hair density.

FPHL common in Taiwanese women; risk factors include BMI, high glucose, early puberty, fewer childbirths, oral contraceptives, and UV exposure.

Finasteride reduces hair growth and is safe for women with excessive hair.

Sex hormones affect brain injury differently in males and females.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Dutasteride safely promotes hair growth and reduces hair loss, with mild side effects.

Men can report their own balding patterns well enough for large health studies.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Finasteride can cause serious emotional side effects; doctors should check patients' mental health history before prescribing.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Understanding glycans and enzymes that alter them is key to controlling hair growth.

Genetics affect early female hair loss, severity depends on duration, and low ferritin levels not significant.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.